Advertisement

Which events to consider in the study of venous thromboses in pancreatic cancer patients? Authors' reply

Published:January 17, 2023DOI:https://doi.org/10.1016/j.ejim.2023.01.013
      We appreciate the comments made by Debourdeau et al. [
      • Debourdeau P.
      • Launay S.
      • Chaouche M.
      Which events to consider in the study of venous thromboses in pancreatic cancer patients?.
      ] regarding our recent publication “Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis” [
      • García Adrián S.
      • Rodríguez González A.
      • Martínez de Castro E.
      • Pachón Olmos V.
      • Ortega Morán L.
      • Martínez Del Prado P.
      • et al.
      Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Debourdeau P.
        • Launay S.
        • Chaouche M.
        Which events to consider in the study of venous thromboses in pancreatic cancer patients?.
        Eur J Intern Med. 2022; S0953-6205 (00407-1)https://doi.org/10.1016/j.ejim.2022.11.017
        • García Adrián S.
        • Rodríguez González A.
        • Martínez de Castro E.
        • Pachón Olmos V.
        • Ortega Morán L.
        • Martínez Del Prado P.
        • et al.
        Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.
        Eur J Intern Med. 2022; 105: 30-37https://doi.org/10.1016/j.ejim.2022.07.020
        • Muñoz F.J.
        • Mismetti P.
        • Poggio R.
        • Valle R.
        • Barrón M.
        • Guil M.
        • Monreal M.
        • Invetigators R.I.E.T.E.
        Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry.
        Chest. 2008; 133: 143-148https://doi.org/10.1378/chest.07-1432
        • Frere C.
        • Bournet B.
        • Gourgou S.
        • Fraisse J.
        • Canivet C.
        • et al.
        BACAP Consortium. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
        Gastroenterology. 2020; 158 (e4): 1346-1358https://doi.org/10.1053/j.gastro.2019.12.009
        • Carrier M.
        • Le Gal G.
        • Wells P.S
        Preventing Venous Thromboembolism in Patients with Cancer. Reply.
        N Engl J Med. 2019; 380: 2181https://doi.org/10.1056/NEJMc1904003
        • Khorana A.A.
        • Mones J.
        • Soff G.A.
        Preventing Venous Thromboembolism in Patients with Cancer. Reply.
        N Engl J Med. 2019; 380: 2181https://doi.org/10.1056/NEJMc1904003
        • Li A.
        • Brandt W.
        • Brown C.
        • Wang T.F.
        • Ikesaka R.
        • Delluc A.
        • Wells P.
        • Carrier M.
        Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: a systematic review and meta-analysis.
        Thromb Res. 2021; 208: 58-65https://doi.org/10.1016/j.thromres.2021.10.012